Revenue Breakdown
Composition ()
No data
Revenue Streams
Medline Inc (MDLN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Supply Chain Solutions, accounting for 52.9% of total sales, equivalent to $3.89B. Other significant revenue streams include Medline Brand - Front Line Care and Medline Brand - Surgical Solutions. Understanding this composition is critical for investors evaluating how MDLN navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Medline Inc maintains a gross margin of 22.65%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.18%, while the net margin is 3.25%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively MDLN converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, MDLN competes directly with industry leaders such as EW and IDXX. With a market capitalization of $47.08B, it holds a significant position in the sector. When comparing efficiency, MDLN's gross margin of 22.65% stands against EW's 78.01% and IDXX's 63.35%. Such benchmarking helps identify whether Medline Inc is trading at a premium or discount relative to its financial performance.
